Ion Beam Applications SA (EBR:IBAB)

Market Cap	384.09M +18.4%
Revenue (ttm)	620.20M +24.5%
Net Income	12.70M +37.3%
EPS	0.43 +37.0%
Shares Out	29.23M
PE Ratio	30.56
Forward PE	10.63
Dividend	0.25 (1.90%)
Ex-Dividend Date	Jun 18, 2025

Volume	46,182
Average Volume	37,807
Open	13.00
Previous Close	12.88
Day's Range	12.84 - 13.14
52-Week Range	9.49 - 15.90
Beta	1.22
RSI	43.04
Earnings Date	Mar 27, 2026

About Ion Beam Applications

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production o...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,100
• Stock Exchange: Euronext Brussels
• Ticker Symbol: IBAB

Financial Performance

In 2025, Ion Beam Applications's revenue was 620.20 million, an increase of 24.50% compared to the previous year's 498.16 million. Earnings were 12.70 million, an increase of 37.25%.